Craig Lipset is a pioneering force in clinical trial innovation who transforms how medical research connects with patients. His unique perspective combines pharmaceutical leadership with personal experience as a rare disease patient, making him a powerful advocate for patient-centered research approaches.

As former Head of Clinical Innovation at Pfizer and founding member of TransCelerate Biopharma, Craig led groundbreaking initiatives including the first fully remote clinical trial and pioneered returning research results to participants. He founded Clinical Innovation Partners and co-chairs the Decentralized Trials & Research Alliance (DTRA), a global non-profit with over 100 member organizations.

Craig helps organizations navigate the complex intersection of technology, patient engagement, and regulatory compliance in clinical research. His expertise enables pharmaceutical companies and research institutions to implement decentralized trial models that expand participant access while maintaining scientific integrity. His methodologies have demonstrably reduced recruitment timelines and increased participant diversity in clinical studies.

Audiences gain practical frameworks for implementing patient-centric trial designs, strategies for leveraging digital technologies to enhance research accessibility, and insights into regulatory considerations for innovative trial approaches. Craig's presentations blend strategic vision with actionable implementation guidance.

Book Craig to equip your organization with proven approaches that transform clinical research from an institutional process into a patient-centered experience that accelerates medical innovation.